Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
10.99B
Market cap10.99B
Price-Earnings ratio
-61.49
Price-Earnings ratio-61.49
Dividend yield
Dividend yield
Average volume
857.30K
Average volume857.30K
High today
$233.86
High today$233.86
Low today
$224.95
Low today$224.95
Open price
$232.31
Open price$232.31
Volume
860.49K
Volume860.49K
52 Week high
$237.86
52 Week high$237.86
52 Week low
$144.26
52 Week low$144.26

Stock Snapshot

With a market cap of 10.99B, Charles River(CRL) trades at $228.22. The stock has a price-to-earnings ratio of -61.49.

During the trading session on 2026-07-15, Charles River(CRL) shares reached a daily high of $233.86 and a low of $224.95. At a current price of $228.22, the stock is +1.5% higher than the low and still -2.4% under the high.

Trading volume for Charles River(CRL) stock has reached 860.49K, versus its average volume of 857.3K.

Over the past 52 weeks, Charles River(CRL) stock has traded between a high of $237.86 and a low of $144.26.

Over the past 52 weeks, Charles River(CRL) stock has traded between a high of $237.86 and a low of $144.26.

CRL News

MarketWatch 2d
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch

...

Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch
TipRanks 2d
Charles River announces collaboration with Arovella Therapeutics

Charles River (CRL) Laboratories International announced a collaboration with Arovella Therapeutics. The collaboration helps Arovella achieve its goal of creati...

Simply Wall St 3d
Charles River Laboratories International Expands AI Pathology Platform, Is The Valuation Upside Already Priced In?

Advertisement AI Pathology Expansion and Fresh Highs Focus Attention on Charles River Laboratories International Charles River Laboratories International (CRL...

Charles River Laboratories International Expands AI Pathology Platform, Is The Valuation Upside Already Priced In?

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
20%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.